Table 4 Clinical characteristics and drug resistance patterns of the patients (N = 115)
Variable | Patients, N (%) |
|---|---|
Sputum grading | |
Low | 47 (40.9) |
High | 68 (59.1) |
Baseline lung cavity | |
No | 68 (59.1) |
Yes | 47 (40.9) |
Positive culture at the end of the second month | |
No | 67 (58.3) |
Yes | 48 (41.7) |
Creatinine level | |
Normalα | 105 (91.3) |
Above normal | 10 (8.7) |
Hb level | |
Normalα | 47 (40.9) |
Below normal | 68 (59.1) |
WBC count | |
Normalα | 78 (67.8) |
Above normal | 37 (3.2) |
Bilirubin level | |
Normalα | 106 (92.2) |
Above normal | 9 (7.8) |
Comorbidity | |
No | 85 (73.9) |
Yes | 30 (26.1) |
Type of comorbidity | |
Diabetes mellitus | 12 (40) |
Hepatitis | 3 (10) |
Hypertension | 8 (26.7) |
Chronic obstructive pulmonary disease | 2 (6.7) |
HIV | 5 (16.6) |
Resistance to TB drugs | |
HR | 80 (69.6) |
HRE | 11 (9.6) |
HRS | 10 (8.7) |
HRES | 14 (12.1) |